June 4 - 6, 2013    Philadelphia PA , Etats-Unis d’Amérique
The Targeting Parkinson’s Disease symposium will address both disease modification and therapeutic development for levodopa induced dyskinesia, an unmet medical need within Parkinson’s treatment, and other PD-treatment symptoms. Advances in target identification, biomarker development, and genetics (such as LRKK2 and alpha-synuclein) will also be discussed.

Lieux de Rendez-Vous

Location: Loews Philadelphia Hotel
Contact 1200 Market Street Philadelphia , USA

Evénements Liés